4-(β-chloro-isopropyl)-morpholine; hydrochloride | 98338-40-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 4-(β-chloro-isopropyl)-morpholine; hydrochloride
• 英文别名: 4-(β-Chlor-isopropyl)-morpholin; Hydrochlorid；4-(1-Chloropropan-2-yl)morpholin-4-ium;chloride
• CAS: 98338-40-0
• 化学式: C₇H₁₄ClNO*ClH
• 分子量: 200.108
• InChiKey: GYCYLJUJODVGEJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.37
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-吗啉-4-基丙烷-1-醇 在 氯化亚砜 作用下， 以 氯仿 为溶剂， 生成 4-(β-chloro-isopropyl)-morpholine; hydrochloride
  参考文献：
  名称：

  法尔顿·冯·梅萨登·尼特尔和伊索塔顿·尼特里·索维·韦根登根

  摘要：

  使2-氯-1-二烷基氨基丙烷4a-d在相转移条件下与二苯基乙腈反应，得到腈1a-d和2a-d的混合物。氯-二烷基氨基-1-苯基乙烷7a-d和8a-d均导致4-二烷基氨基-2,2,3-三苯基-丁腈6a-d。

  DOI：

  10.3797/scipharm.aut-00-21

文献信息

• [EN] COMPOUNDS THAT INHIBIT MCL-1 PROTEIN<br/>[FR] COMPOSÉS INHIBANT LA PROTÉINE MCL-1
  申请人：AMGEN INC

  公开号：WO2017147410A1

  公开（公告）日：2017-08-31

  Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.

  本文提供了髓样细胞白血病1蛋白（Mcl-1）抑制剂，其制备方法，相关的药物组合物，以及使用这些物质的方法。例如，本文提供了化合物I的公式，及其药用盐和含有这些化合物的药物组合物。本文提供的化合物和组合物可以用于治疗癌症等疾病或症状。
• COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
  申请人：AMGEN INC.

  公开号：US20210230189A1

  公开（公告）日：2021-07-29

  Provided herein are myeloid cell leukemia 1 protein (Mcl-1) inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I, and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.
• [EN] ISOQUINOLINE DERIVATIVES AS PDE4 INHIBITORS<br/>[FR] DERIVES D'ISOQUINOLINE INHIBITEURS DE PDE4
  申请人：SANOFI SYNTHELABO

  公开号：WO2001064647A1

  公开（公告）日：2001-09-07

  Compounds of the general formula (I) wherein R10 means saturated 4 to 7 membered ring containing one or two nitrogen atom(s) connecting through the nitrogen atom and optionally substituted by a C¿1-4? alkyl group or a satured 4 to 7 membered ring containing one nitrogen atom and one oxygen atom connecting through the nitrogen atom and optionally substituted by a C1-4 alkyl group, X stands for sulfur atom or oxygen atom, are strong and selective inhibitors of PDE4 enzyme and they are presumably suitable for the treatment of for instance asthma, chronic obstructive pulmonary disease (COPD) and rheumatoid arthritis.
• Betrachtungen zur Herstellung von Methadon-nitril und Isomethadon-nitril sowie verwandten Verbindungen
  作者：B. Unterhalt、B. Coesfeld

  DOI：10.3797/scipharm.aut-00-21

  日期：——

  The 2-chloro-1-dialkylamino-propanes 4a-d are reacted with diphenylacetonitrile under phase transfer conditions to give a mixture of the nitriles 1a-d and 2a-d. Both chloro-dialkylamino-1-phenyl-ethanes 7a-d and 8a-d lead to 4-dialkylamino-2,2,3-triphenyl-butyronitriles 6a-d.

  使2-氯-1-二烷基氨基丙烷4a-d在相转移条件下与二苯基乙腈反应，得到腈1a-d和2a-d的混合物。氯-二烷基氨基-1-苯基乙烷7a-d和8a-d均导致4-二烷基氨基-2,2,3-三苯基-丁腈6a-d。